We have demonstrated that PI3Kγ inhibition combined with the ENO1 DNA vaccine reduces tumor growth, increases immune infiltration at tumor sites, modulates the TME and strongly potentiates the ENO1-specific humoral and cellular responses. The gene discussed is ENO1; the disease is neoplasm.